Cancer Advances Announces Issuance of a New Patent for a Companion…
Cancer Advances, Inc. (Cancer Advances), a wholly owned, biotechnology portfolio company of Cato BioVentures, announces the issuance of a new patent for a companion diagnostic, to be used as a…(PRWeb July 31, 2012)Read the full story at http://www…
Cancer Advances Announces Issuance of a New Patent for a Companion… Read Post »
